Background and Purpose-Recently, a genome-wide association study identified associations between single nucleotide polymorphisms on chromosome 9p21 and risk of harboring intracranial aneurysm (IA). Aneurysm characteristics or subphenotypes of IAs, such as history of subarachnoid hemorrhage, presence of multiple IAs and location of IAs, are clinically important. We investigated whether the association between 9p21 variation and risk of IA varied among these subphenotypes. Methods-We conducted a case-control study of 981 cases and 699 controls in Japanese. Four single nucleotide polymorphisms tagging the 9p21 risk locus were genotyped. The OR and 95% CI were estimated using logistic regression analyses. Results-Among the 4 single nucleotide polymorphisms, rs1333040 showed the strongest evidence of association with IA (Pϭ1.5ϫ10
T he rupture of an intracranial aneurysm (IA) is the most common cause of subarachnoid hemorrhage (SAH) associated with high morbidity and mortality. IA is implicated to be a multifactorial disease in which multiple genes and environmental factors influence disease risk. 1 Recently, a multistage genome-wide association study of Finnish, Dutch, and Japanese cohorts identified associations between single nucleotide polymorphisms (SNPs) on chromosomes 2q33, 8q11, and 9p21 and the susceptibility to IA. 2 Among the three loci, the 9p21 locus seems most intriguing because SNPs identified by the genome-wide association study of IA are in linkage disequilibrium with SNPs associated with several other arterial diseases (coronary artery disease, abdominal aortic aneurysm, and peripheral arterial disease), 3 and the 9p21 risk locus overlaps a newly annotated noncoding RNA, called ANRIL (or CDKN2BAS). 4 Patient characteristics such as gender, age, smoking habit, and history of hypertension are well-established risk factors affecting formation, growth, and rupture of IA. 1 Furthermore, aneurysm characteristics such as the history of SAH, presence of multiple IAs, and location of IA (hereinafter, referred to as "subphenotypes" of IA) are clinically important because they are associated with the outcome of patients with IA. 5, 6 Genetic dissection of IA subphenotypes is essential but uncharted territory. 7 We conducted a case-control study in the Japanese population to evaluate the possibility of confounding or effect modification of the 9p21 association through the environmen-tal risk factors and to investigate whether the association between the 9p21 variation and risk of IA varied according to subphenotype.
Materials and Methods

Study Participants
All study participants were Japanese and recruited at Tokyo Women's Medical University, Chiba University, and their affiliated hospitals. The Ethics Committee of Tokyo Woman's Medical University, Chiba University, and Tokai University approved the study protocols and all participants gave written informed consent.
Nine hundred eighty-one IA patients included 322 familial IA patients (80 probands from nuclear families that had been used in our linkage study 8 and 242 patients who had a family history of IA) and 659 sporadic IA patients. The presence of IA was confirmed by digital subtraction angiography, 3-dimensional computed tomography angiography, magnetic resonance angiography, or surgical findings. Phenotyping of IAs, such as aneurysm location and number of aneurysms, was performed by certified neurosurgeons. The patients harboring saccular IA were included, but those harboring fusiform or dissecting IA were excluded. All 699 controls were screened for not harboring IA by means of neuroradiological imaging such as MRI. IA patients and controls were classified as hypertensive if they had a medical history of hypertension or were currently receiving antihypertensive therapy. The subjects were divided into 2 groups according to their self-reported smoking habit: never-smokers and ever-smokers. The dataset was updated from our previous studies. 2, 8 Baseline characteristics of the study participants are summarized in Table 1 .
SNP Genotyping
All study participants were genotyped for 4 9p21 SNPs (rs1333040, rs2891168, rs2383207, and rs10757278). These SNPs were selected as tag SNPs capturing SNPs previously reported to show strong association to IA, coronary artery disease, abdominal aortic aneurysm, and peripheral arterial disease 2,3,9 -13 at r 2 Ͼ0.9 in phase II HapMap JPT (Japaneses in Tokyo, Japan) samples. Linkage disequilibrium structure and selection criterion of the SNPs are shown in Supplemental Figure I available online at http://stroke.ahajournals. org. Genotyping was performed by TaqMan SNP Genotyping Assays on the ABI PRISM 7900HT Sequence Detection System (Applied Biosystems) or by direct sequencing with BigDye Terminators v3.1 Cycle Sequencing Kit on the Applied Biosystems 3730 DNA analyzer (Applied Biosystems).
Statistical Analysis
The statistical significance of departure from Hardy-Weinberg equilibrium in control samples was examined by means of the exact test using PLINK software. 14 We assessed the significance of association using the Cochran-Armitage trend test. To determine the most likely genetic model, additive and nonadditive effects were modeled in the context of logistic regression analysis by defining the SNP genotype predictor value x 1 and x 2 as x 1 ϭ ͭ The stepwise logistic regression procedure was applied to assess the relative importance of the 4 SNPs. The significance level of 0.01 was necessary for entering a SNP into the model, and the significance level of 0.01 was necessary for a SNP to stay in the model at any iteration step. When applying the stepwise logistic regression procedure, missing genotypes were imputed via Beagle software 15 with default settings. The accuracy of the imputation was assessed by means of the R 2 values (ie, the estimates of the squared correlation between the imputed allele dosage and the true allele dosage). 15 The resulting phased genotype data were used for haplotype analysis.
ORs of IA for the selected SNP and 2 risk factors (smoking habit and history of hypertension) were estimated by logistic regression analysis using a univariate analysis for each predictor, and then a multivariate model including all the predictors with adjustment for . . . *The data regarding smoking habit and history of hypertension were incomplete. Differences between total and analyzed sample size were attributable to missing data.
†The analyses concerning history of SAH and site distribution of aneurysms was restricted to 713 patients who had a single aneurysm because patients with multiple IAs may simultaneously have different types of IAs, which makes it difficult to select the correct subphenotype, eg, patients with both ruptured and unruptured IAs.
The International Study of Unruptured Intracranial Aneurysm (ISUIA) 5 classified IA sites into the following two groups: AC/MC/IC, aneurysms in ACA, AcomA, ICA or MCA; and Post-Pcomm, those in BA, VA, PCA or PcomA.
ACA indicates anterior cerebral artery; AcomA, anterior communicating artery; BA, basilar artery; IA, intracranial aneurysm; ICA, internal carotid artery (not the cavernous portion); MCA, middle cerebral artery; Others, the cavernous portion of the ICA or unknown; PCA, posterior cerebral artery; PcomA, posterior communicating artery; SAH, subarachnoid hemorrhage; VA, vertebral artery.
gender and age (Ͻ50, 50 -59, 60 -69, Ն70 years) to address possible confounding. We investigated whether the magnitude of the association between the 9p21 SNP and IA was modified by the risk factors. The joint association of the 9p21 genotype and each risk factor with IA was evaluated. Six categories were formed by combining the 9p21 genotype (AA, Aa, aa) and either smoking habit (ever, never) or history of hypertension (yes, no). Furthermore, interactions between 9p21 and risk factor were investigated by adding a product term into the multivariate logistic regression model to assess whether deviations from multiplicative joint effects were statistically significant (or to examine whether the joint effects were significantly greater or smaller than expected).
To evaluate whether the association between the 9p21 SNP and risk of harboring IA varied according to subphenotypes, we examined the association between the 9p21 SNP and IA according to subgroups stratified by history of SAH (ruptured or unruptured), multiplicity of IA (multiple or single), and location of the IA. When analyzing the history of SAH and location of IA, we excluded patients with multiple IAs because some patients with multiple IAs simultaneously had different types of aneurysms according to the SAH status or aneurysm location (eg, patients with ruptured and unruptured IAs). Thus, 713 patients harboring a single IA were analyzed.
For the subgroup analysis regarding location of IA, the definition of 2 sets of case-subgroups was as follows: (1) patients harboring IA at 3 common sites (anterior communicating artery [AcomA], middle cerebral artery [MCA] , and posterior communicating artery [PcomA]), which we defined as the site where the number of patients was Ͼ100; and (2) patients grouped according to the International Study of Unruptured Intracranial Aneurysm 5 : (i) AC/MC/IC, which signify aneurysms in the AcomA, the anterior cerebral artery (ACA), the MCA, or the internal carotid artery (ICA) (not the cavernous portion) and (ii) Post-Pcomm, meaning the vertebrobasilar, the posterior cerebral arterial system, or the PcomA. Distribution of the IA subphenotypes is seen in Table 1 .
To estimate subphenotype-specific ORs, the frequency of the 9p21 variant in each case-subgroup (eg, patients with ruptured or unruptured IA) was compared with the frequency in controls using a polytomous logistic regression. To assess whether the estimated subphenotype-specific ORs were significantly different, the frequencies of the 9p21 variant were compared between case-subgroups by dichotomous logistic regression (the case-subgroup heterogeneity test). 16 For these subgroup analyses, the effects of gender and age were adjusted. When assessing the subgroup-specific effects stratified by SAH status, the case subgroup heterogeneity test with adjustment for IA site (6 categories: AcomA, ACA, MCA, ICA, PcomA, the posterior cerebral arterial system) was also implemented to keep out possible confounding effects attributable to complex relationships among IA subphenotypes. Similarly, when assessing the subgroup-specific effects stratified by IA sites, the effects of SAH status were adjusted (2 categories: ruptured, unruptured). All the logistic regression analyses were performed by SAS (SAS Institute).
Results
The results of genotyping and association analysis for 4 SNPs on 9p21 are shown in Table 2 . For the SNPs, the missing genotype rates were small (at most, 5.2% for rs2891168) and the genotypes for all SNPs were in the Hardy-Weinberg equilibrium in controls (PϾ0.05). All the SNPs showed highly significant associations with IA by means of the trend test (Pϭ1.5ϫ10 Ϫ6 for rs1333040; Pϭ7.4ϫ10 Ϫ5 for rs2891168; Pϭ8.3ϫ10 Ϫ5 for rs2383207; Pϭ4.1ϫ10 Ϫ5 for rs10757278). The effect of nonadditivity was not significant for any SNP (PϾ0.05); therefore, the multiplicative model was selected as an appropriate genetic model and applied in subsequent logistic regression analyses.
For the stepwise logistic regression analysis, the missing genotype imputation was implemented. The estimated R 2 values were Ͼ0.98 for all the SNPs, indicating that accuracy of the imputation was considerably high. The stepwise logistic regression analysis identified rs1333040 as an independent predictor of IA among the 4 SNPs. The observed associations of the other 3 SNPs could be a result of linkage disequilibrium with rs1333040. Haplotype analysis reinforces this inference. All but 1 of 4 common haplotypes bearing T allele of rs1333040 (ie, H3, H5, and H6) was significantly associated with IA, whereas haplotype H2 bearing the C allele of rs1333040 and the risk alleles of the other 3 SNPs did not show significant association (Table 3) . Thus, only rs1333040 was considered in further analyses.
The ORs obtained from both univariate and multivariate logistic regression analyses are shown in The result of the joint association of rs1333040 and each risk factor is displayed in Supplemental Figure II available online at http://stroke.ahajournals.org, which shows that the effect of environmental exposure (smoking or hypertension) did not differ among subjects stratified by genotypes on a multiplicative (log-odds) scale and vice versa. Furthermore, the tests for deviations from multiplicative joint effects were not significant; the ORs for the genotype-smoking and genotype-hypertension interactions were 1.08 (95% CI, 0.76 -1.53; Pϭ0.67) and 1.22 (95% CI, 0.86 -1.72; Pϭ0.27), respectively.
The associations between rs1333040 and IA subdivided by aneurysmal subphenotypes were examined in the context of the polytomous logistic regression analyses. The subphenotypespecific ORs are shown in the Figure. The subgroup analysis stratified by SAH status showed that rs1333040 was associated with ruptured IA (OR, 1.42; 95% CI, 1.18 -1.71) and unruptured IA (OR, 1.27; 95% CI, 1.00 -1.62). The difference in OR between ruptured and unruptured IAs was not significant in terms of the case-subgroup heterogeneity test (Pϭ0.42). This was confirmed by the case-subgroup heterogeneity test with adjustment for IA site (Pϭ0.69).
When stratifying patients with a single IA by 3 common sites, the association was strongest for PcomA (OR, 1.69; 95% CI, 1.26 -2.26), secondly for MCA (OR, 1.36; 95% CI, 1.07-1.72), and not significant for AcomA (OR, 1.22; 95% CI, 0.96 -1.57). Then, the difference in OR between PcomA and AcomA was suggestive by the case-subgroup heterogeneity test (Pϭ0.067). However, the case-subgroup heterogeneity tests were not significant (Pϭ0.50 for AcomA vs MCA and Pϭ0.23 for MCA vs PcomA). When dichotomizing IA sites according to the grouping in the International Study of Unruptured Intracranial Aneurysm, the association was stronger for Post-Pcomm (OR, 1.73; 95% CI, 1.32-2.26) than for AC/MC/IC (OR, 1.28; 95% CI, 1.07-1.53). We found the difference between these ORs was statistically significant in the case-subgroup heterogeneity test (Pϭ0.032). To consider a possible relationship between location of IA and SAH status, the difference among the site-specific ORs was also assessed with adjustment for SAH status. The resulting P values for the case-subgroup heterogeneity tests were Pϭ0.055 for AcomA vs PcomA and Pϭ0.031 for PostPcomm vs AC/MC/IC. These results indicate that the 9p21 SNP is more strongly associated with IA in the posterior circulation or PcomA than that in the anterior circulation.
Discussion
We selected 4 9p21 SNPs to capture SNPs showing strong association with several arterial diseases in previous studies and then confirmed that the SNPs were associated with IA in Japanese. Among the 4 SNPs, rs1333040 showed the strongest evidence of association. The stepwise logistic regression analysis and the haplotype analysis reveal that the sequence variant tagged by the T allele of rs1333040 can explain the observed association with IA. Recently, the association between the 9p21 locus and IA was confirmed in a white population that was independent from populations analyzed in the original genome-wide association study. 17 We found that the association was independent of established risk factors (gender, age, smoking, and hypertension). The presence of missing data on smoking and hypertension was a limitation of our study. However, similar findings were observed in case-control studies of IA and coronary artery disease; the effect of the 9p21 locus on risk of IA and coronary artery disease was not altered by adjustment for the risk factors. 12, 17, 18 This may support the validity of our result. *The haplotype phasing was performed using Beagle software. 15 †Six common haplotypes whose frequencies exceeded 1% were analyzed. ‡OR and 95% CI for each haplotype was estimated by setting haplotype H1, bearing no putative susceptibility allele at every SNP site, as the reference category.
The omnibus haplotype test with the degree of freedom of 5 was also performed. The likelihood ratio 2 statistic was 29.017 and the resulting P value was 2.2ϫ10 Ϫ5 . *Multivariate logistic regression model that included all these predictors with adjustment for gender and age (Ͻ50, 50 -59, 60 -69, Ն70). In the multivariate logistic regression analysis, we used data from 768 cases and 626 controls with complete information for all the variables.
The most important findings of this study are that rs1333040 was more strongly associated with IA of the PcomA and the posterior circulation than with IA in the anterior circulation. In terms of common sites, we found that the T allele of rs1333040 was associated with a 1.69-fold increased risk of IA in PcomA relative to the low-risk allele C, whereas the increased risk of IA in AcomA was only 1.22-fold.
To our knowledge, this is the first study showing that a common genetic variant with widely replicated evidence is associated with site distribution of IA. Epidemiological studies reinforce the hypothesis that genetic components influence site distribution of IA. There were considerably high concordance rates of IAs at identical or mirror-image sites in twins (70%) 19 and in sibling pairs (69%), 20 whereas the concordance rate in randomly selected pairs of patients was only 21%. 19 These findings suggest that the 9p21 variant is one of the genetic factors predisposing to IAs in specific locations. Recently, Lindner et al 21 demonstrated that the effects of established risk factors (gender, age, and alcohol intake) were different according to the site of aneurysms. This finding suggests that there is a possibility that the effects of genetic risk factors may also differ according to the site of aneurysms. The natural history of IAs in the anterior circulation and the posterior circulation and the PcomA are different. The posterior group of aneurysms is associated with a higher risk of rupture and poorer surgical and endovascular outcomes compared to the anterior circulation aneurysms. 5, 6 In the future, functional analyses focusing on differential gene expressions of aneurysm dome tissue subdivided by arterial sites may identify susceptibility genes and polymorphisms responsible for the formation of each subphenotype of IA and may help further understand the pathogenesis of this complex disease.
The effect of 9p21 SNP was not different when stratifying IA patients by SAH status. This finding suggests that the 9p21 risk locus may be involved in the formation of IA rather than in the precipitation of the aneurysm rupture.
It is known that subphenotypes of IAs show common characteristics, eg, the risk of aneurysm rupture is associated with aneurysm size and location. 5, 6 It is important to rule out possible confounding effects within the groups of IA subphenotypes. The analytical methods used in this study worked well for subgroup analyses regarding history of SAH and location of IA. The analysis for multiplicity of IA is more complex because of the presence of several subphenotypes in 1 patient eg, aneurysm at the AcomA and the MCA. Further sophisticated and large-scale analyses are needed to identify susceptibility genes of multiplicity of IA.
Some limitations of our study should be noted. All the current analyses are based on statistical analyses; therefore, functional analysis of rs1333040 or other SNP that is in linkage disequilibrium with rs1333040 is necessary. Although the diagnostic performance of the noninvasive imaging methods for the evaluation of IAs has been significantly improved, the use of magnetic resonance angiography and computed tomography angiography may be subject to misclassification of IA subphenotypes as compared to digital subtraction angiography and surgical findings. Subgroup analyses are subject to inflated false-positive rates attributable to multiple testing. 22, 23 The main conclusion of this study is based on 6 case-subgroup heterogeneity tests to assess whether the estimated subphenotype-specific ORs were significantly different. For simplicity, when we assume the tests are unrelated, 6 tests may produce a 26% chance of observing at least 1 significant result at the significance level of 0.05. Therefore, independent replication studies and meta-analyses integrating results from original and subsequent replication studies are indispensable to establish the credibility of the findings. 22, 23 We dichotomized aneurysm sites according to the grouping in the International Study of Unruptured Intracranial Aneurysm, 5 but there may be controversy regarding the grouping of the PcomA aneurysms because the PcomA derives from the ICA. 24 Therefore, both of the findings when IA patients are stratified according to the International Study of Unruptured Intracranial Aneurysm grouping and according to the common site will be corroborated.
Conclusion
One of the difficulties in genetic dissection of IA may be attributable to possible phenotypic heterogeneity. 1, 7 In most association studies, patients with different aneurysmal pheno- Table 1 . The vertical dotted line shows OR for single IA patients because we restricted analyses to patients with single IA for subgroup analyses regarding history of subarachnoid hemorrhage and location of IA. All the ORs were estimated with adjustment for gender and age.
types were grouped together. 7 If different predisposition underlies different subphenotypes of IA, then reducing phenotypic heterogeneity by restricting to specific subphenotype would be effective. We assessed whether the magnitude of the 9p21 association varied by aneurysmal subphenotypes. Our results of the 9p21 variation being associated with location of IA suggest that a genetic dissection of subphenotypes of IA is important and feasible. One of the most important aspects of IAs is whether they will rupture. The analytical methods implemented in this study may be useful to identify a genetic factor that allows prediction of aneurysmal rupture.
